Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1998 1
2000 1
2001 2
2002 55
2003 52
2004 86
2005 95
2006 141
2007 149
2008 201
2009 195
2010 230
2011 233
2012 281
2013 342
2014 347
2015 374
2016 395
2017 380
2018 398
2019 426
2020 461
2021 492
2022 412
2023 367
2024 172

Text availability

Article attribute

Article type

Publication date

Search Results

5,524 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: lee jl. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Among authors: lee jl. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Reply.
Kim HT, Kim JM, Kim JH, Lee JH, Lee MY, Lee JY, Won YS, Park KH, Kwon HS; Korean Ophthalmological Society. Kim HT, et al. Among authors: lee jy, lee jh. Am J Ophthalmol. 2017 May;177:241-242. doi: 10.1016/j.ajo.2017.03.015. Epub 2017 Mar 28. Am J Ophthalmol. 2017. PMID: 28363330 No abstract available.
Global varicella vaccination programs.
Lee YH, Choe YJ, Lee J, Kim E, Lee JY, Hong K, Yoon Y, Kim YK. Lee YH, et al. Among authors: lee jy. Clin Exp Pediatr. 2022 Dec;65(12):555-562. doi: 10.3345/cep.2021.01564. Epub 2022 Nov 2. Clin Exp Pediatr. 2022. PMID: 36457198 Free PMC article.
Breast sparganosis.
Kim WY, Woo SU, Son GS, Lee JB, Bae JW. Kim WY, et al. Among authors: lee jb. Breast J. 2013 Mar-Apr;19(2):208-9. doi: 10.1111/tbj.12089. Epub 2013 Jan 7. Breast J. 2013. PMID: 23294375 No abstract available.
Links of Cytoskeletal Integrity with Disease and Aging.
Kim YJ, Cho MJ, Yu WD, Kim MJ, Kim SY, Lee JH. Kim YJ, et al. Among authors: lee jh. Cells. 2022 Sep 16;11(18):2896. doi: 10.3390/cells11182896. Cells. 2022. PMID: 36139471 Free PMC article. Review.
[Inflammatory Hepatic Adenoma].
Lee JS, Jeong EK, Kim EK, An C, Kim HG, Kim SU, Han KH. Lee JS, et al. Korean J Gastroenterol. 2015 Jul;66(1):59-63. doi: 10.4166/kjg.2015.66.1.59. Korean J Gastroenterol. 2015. PMID: 26410896 Free article. Korean. No abstract available.
Aortic valve: To buy or not to buy?
Kim J, Lee JW. Kim J, et al. Among authors: lee jw. J Thorac Cardiovasc Surg. 2018 Jun;155(6):2388-2389. doi: 10.1016/j.jtcvs.2018.02.031. Epub 2018 Feb 17. J Thorac Cardiovasc Surg. 2018. PMID: 29555090 Free article. No abstract available.
5,524 results